Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Jan 10, 2011 10:34am
436 Views
Post# 17947719

Noticed on the NASDAQ

Noticed on the NASDAQ

HEMISPHERE GPS SET TO POSSIBLY PULLBACK AFTER YESTERDAY'S RALLY OF 18.25% (HEMGF)

Print    Share
Jan 10, 2011 (SmarTrend(R) News Watch via COMTEX) -- Hemisphere GPS (NASDAQ:HEMGF) traded in a range yesterday that spanned from a low of $1.45 to a high of $1.57. Yesterday, the shares gained 18.25%, which took the trading range above the 3-day high of $1.26 on volume of 121,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Shares of Hemisphere GPS are currently trading above their 50-day moving average (MA) of
.81 and above their 200-day MA of
.88. Look for the MA to provide support for a short-term pullback in the shares.

SmarTrend currently has shares of Hemisphere GPS in an Uptrend and issued the Uptrend alert on October 12, 2010 at
.84. The stock has risen 50% since the Uptrend alert was issued.

SmarTrend expects the share price to pullback toward the $1.26 support level. Afterwards, we expect it to move upward with its peers in the SmarTrend Wireless Communications industry.

Write to Chip Brian at cbrian@tradethetrend.com

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse